Legal Representation
Attorney
Michael J. Femal
USPTO Deadlines
Application History
19 events| Date | Code | Type | Description |
|---|---|---|---|
| Dec 30, 2019 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED |
| Dec 30, 2019 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| May 30, 2019 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| May 28, 2019 | EEXT | I | SOU TEAS EXTENSION RECEIVED |
| May 28, 2019 | EXT1 | S | SOU EXTENSION 1 FILED |
| May 28, 2019 | EX1G | S | SOU EXTENSION 1 GRANTED |
| Nov 27, 2018 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Oct 2, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION |
| Oct 2, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Sep 12, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Aug 23, 2018 | ALIE | A | ASSIGNED TO LIE |
| Aug 14, 2018 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Aug 3, 2018 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN |
| Aug 3, 2018 | GNEA | F | EXAMINERS AMENDMENT E-MAILED |
| Aug 3, 2018 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Aug 3, 2018 | XAEC | I | EXAMINER'S AMENDMENT ENTERED |
| Jul 27, 2018 | DOCK | D | ASSIGNED TO EXAMINER |
| Apr 17, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Apr 12, 2018 | NWAP | I | NEW APPLICATION ENTERED |
Detailed Classifications
Class 005
Antiallergic medicines; Pharmaceutical preparations, namely, a blood clotting aid and delivery system for use in human and veterinary medicine; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders
First Use Anywhere:
0
First Use in Commerce:
0
Class 035
Providing an on-line searchable database featuring referrals in the field of Medicine; Providing an on-line searchable database featuring referrals in the field of human and animal drug therapy; Regulatory submission management, namely, assisting others in preparing and filing applications for new drugs with governmental regulatory bodies; Supplying prescription drugs to health plan participants for the funding organizations
First Use Anywhere:
0
First Use in Commerce:
0
Class 040
Custom manufacture of drugs to save lives by pharmaceutical compounders; Custom manufacture of drugs for cardiovascular therapy by pharmaceutical compounders; Custom manufacture of medicines by pharmaceutical compounders; Custom manufacture of human and animal pharmaceuticals by pharmaceutical compounders
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Development of pharmaceutical preparations and medicines; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Research and development of vaccines and medicines; Scientific study and research in the field of medicines; Scientific study and research in the field of drugs and medicines
First Use Anywhere:
0
First Use in Commerce:
0
Classification
International Classes
005
035
040
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"RX"
USPTO Documents
Loading USPTO documents...